METROPOLITAN LIFE INSURANCE CO/NY - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 78 filers reported holding UROGEN PHARMA LTD in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$15,103
+35.4%
1,0780.0%0.00%0.0%
Q2 2023$11,157
-88.1%
1,078
-80.6%
0.00%0.0%
Q3 2021$93,570
-21.1%
5,563
-8.7%
0.00%
-50.0%
Q1 2021$118,653
+8.1%
6,0910.0%0.00%0.0%
Q4 2020$109,760
-31.0%
6,0910.0%0.00%
-33.3%
Q2 2020$159,097
-7.6%
6,091
-15.7%
0.00%0.0%
Q3 2019$172,2197,2270.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q4 2021
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 900,148$23,512,0008.12%
Horton Capital Management, LLC 383,428$10,015,0007.55%
MENORA MIVTACHIM HOLDINGS LTD. 2,954,699$77,177,0001.89%
Phoenix Holdings Ltd. 897,464$22,251,0000.94%
SHIKIAR ASSET MANAGEMENT INC 51,175$1,337,0000.61%
Migdal Insurance & Financial Holdings Ltd. 738,302$19,284,0000.31%
Coastal Bridge Advisors, LLC 37,000$966,0000.31%
Clal Insurance Enterprises Holdings Ltd 529,388$13,828,0000.27%
ALGERT GLOBAL LLC 10,880$284,0000.10%
BANK HAPOALIM BM 14,831$387,0000.09%
View complete list of UROGEN PHARMA LTD shareholders